# Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study

> **NCT02150863** · NA · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 1 (actual)

## Conditions studied

- Extensive Photodamage
- Actinic Keratosis
- History of Numerous Skin Cancers

## Interventions

- **DEVICE:** Ultrapulse Carbon Dioxide Laser
- **DEVICE:** Cellutome epidermal harvesting system

## Key facts

- **NCT ID:** NCT02150863
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Difficulty enrolling participants due to exclusion and inclusion criteria
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02150863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02150863, "Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02150863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*